Movatterモバイル変換


[0]ホーム

URL:


Logo for the National Academies PressNational Academies Press: OpenBook

Immunization Safety Review: Vaccines and Autism(2004)

Chapter: Appendix E: Summary of Public Submissions

Get This Book
VisitNAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
« Previous:Appendix D: Chronology of Important Events Regarding Vaccine Safety
Page 192ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×

Appendix E
Summary of Public Submissions

Since the announcement of the topic of this report, the committee has received many submissions from the public via mail, email, and fax, all of which were reviewed by the committee to help inform their conclusions and recommendations of this report. A list of all literature and submissions reviewed by the committee can be found on the projects website atwww.iom.edu/imsafety.

The unpublished data reviewed by the committee and cited in this report are available—in the form in which they were reviewed—through the public access files of the National Academies. Information about the public access files can be obtained at 202-334-3543 orwww.national-academies.org/publicaccess.

The committee is thankful to all those who submitted information. Below is a partial list (as of May 1, 2004) of documents received from the public, broken down into six categories.

1)SCIENTIFIC ARTICLES

The committee received recommendations of published articles to review and often hard copies as well. These were too numerous to list here, but a complete list can be viewed at the Public Access Office (contact information listed above). The committee and IOM staff also did an extensive literature review to find all relevant materials. The following people submitted articles, abstracts, and article recommendations to the committee:

  • Sallie Bernard (SafeMinds)

  • Jeff Bradstreet (International Child Development Resource Center)

Page 193ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
  • Amy Carson, Angela Medlin, Karey Williams (Moms Against Mercury)

  • Deborah Darnley

  • Richard C. Deth (professor of pharmacology)

  • Raymond Gallup (The Autism Autoimmunity Project)

  • David A. Geier (President, MedCon, Inc.)

  • Mark R. Geier (President, The Genetic Centers of America)

  • Joseph R. Herr

  • Julio Licinio (Nature Publishing Group)

  • Becky Nelson

  • Lyn Redwood (SafeMinds)

  • Daniel J. Thomasch (Orrick)

  • Lauren Underwood (Developmental Delay Consultant, Inc.)

  • American Autism Association

2)PERSONAL STATEMENTS

The committee received many accounts from parents that described their situation and their child or family member with autism, sometimes with medical histories and/or medical documents enclosed. The committee also received personal statements on the topic of autism and vaccines in general from the following people:

  • American Autism Association; Sponsored by parents of children with autism. We want you to know the truth (folder containing articles, papers, scientific journal articles, and letters).

  • Teresa A. Anderson (Immunization Action Coalition), 2004. Vaccines and Autism.

  • Trish Berger, 2004. Relationship of MMR Vaccine to Autistic Spectrum.

  • James and Kathy Blanco, 2004. Children Left Behind.

  • Kathy Blanco, 2004. Autism Increase

  • Kathy Blanco, 2004. Read at your meeting today, urgent!

  • Robert Chen, 2004. IOM—Vaccines and Autism meeting on 2/9/04

  • Alan Clark, 2004.

  • Deborah Darnley, 2004.Medical records and personal statement

  • Anne Ferreira, 2004. Immunization Safety Review Committee Meeting 9: Vaccines and Autism

  • Maurice Frank, 2004. Media freedom implications of autism vaccine dangers

  • Raymond Gallup, 2004. IOM—Vaccines and Autism

  • Michelle Gibson, 2004. Autism nine feedback

  • Audrey Hamilton, 2004. Autism-vaccines

  • Diane Litt, 2004. MMR Vaccine and autism

  • Donald Meserlian, 2004. VOSI Input for Immunization Safety Review: Vaccines and Autism…Meeting nine

Page 194ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
  • Marjorie H. Monteleon (Maine DEP Dental Mercury Workgroup), 2004. Reference to the Immunization Safety review Committee Meeting 2/9/04.

  • National Autism Association: Folder with stories from the families of children with autism (sponsored by individual parents). We want you to know the truth…

  • Sylvia Nichols, 2004. Autism and Vaccinations.

  • Clarence W. Tiske, 2004. Autism meeting nine, sedation thimerosal.

  • Lauren Underwood, 2004. Immunization Safety Review.

  • Linda Weinmaster, 2004. IOM vaccines and autism public comment.

  • American Autism Assocation; Sponsored by parents of autistic children.

The committee also received several submissions from the public stating potential theories of how vaccines/thimerosal injure children/adults together with unpublished background information and critiques of data.

  • Catherine Boyle, 2004. Immunization Safety Review—vaccines and autism: what about mitochondrial disease underlying autism?

  • Amy Carson, Angela Medlin, Karey Williams (Moms Against Mercury), 2004. Removal of all Mercury Products in Vaccines.

  • Enayati, A. New Autism Data: Slight Decrease May Reflect Mercury Removal from Vaccines (Schafer Autism Report).

  • M.R. Geier, D.A. Geier. 2004. Important additional considerations for the IOM committee on thimerosal.

  • M.R. Geier, D.A. Geier. 2004. New Important Additional Considerations for the IOM committee on Thimerosal II and III.

  • M.R. Geier, D.A. Geier. 2004. VAERS Database Raw Data for Independent Methodology Verification.

  • M.R. Geier, D.A. Geier. 2004. VSD Raw Data: Thimerosal and Autism.

  • Elizabeth Mumper (Advocates for Children, Ltd.), 2004.Letter.

  • J.D. Nordin, M. Goodman, D.M. Smeltzer, E.P. Ehlinger, K. Kephart. 2004. Commentary on data presented by the Geiers at the thimerosal meeting.

  • Lyn Redwood (SafeMinds), 2004. IOM 2-04 RhoD comments.

  • Lyn Redwood (SafeMinds), 2004. IOM 5-04 Primate Study comments.

  • Lyn Redwood (SafeMinds). VSD Comments to IOM 02-16-04.

  • Glen F. Rall (Fox Chase Cancer Center), 2004.Letter.

3)UNPUBLISHED PAPERS

The committee received many unpublished papers to supplement published articles. These include:

  • S. Bernard (SafeMinds), 2004. Analysis of the Autism Registry Data Base in Response to the Hviid et al. Paper on Thimerosal inJAMA (October, 2003).

Page 195ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
  • S. Bernard (SafeMinds), 2003. Analysis and Critique of the CDC’s Handling of the Thimerosal Exposure Assessment Based on Vaccine Safety Datalink (VSD) information.

  • S. Bernard (SafeMinds), 2004. “VSD Thimerosal Analysis of June 2000” Background Information on this Document by SafeMinds.

  • Teresa Binstock (researcher), 2004. Increased susceptibility to adverse effects from vaccinations.

  • M. Blaxill, L. Redwood, S. Bernard (submitted by: SafeMinds). Thimerosal and Autism? A plausible hypothesis that should not be dismissed. A response to: K.B. Nelson and M.L. Bauman. (2003) Thimerosal and Autism?Pediatrics 111(3):674-9.

  • J. Bradstreet, 2004. Biological Evidence of Significant Vaccine Related Side-effects Resulting in Neurodevelopmental Disorders.

  • J. Bradstreet. 2004. Is There a Nexus for MMR and Mercury Issues in Autism Spectrum Disorders.

  • R. Deth, 2004. Molecular Basis of the Link Between Thimerosal and Autism.

  • M. Geier and D. Geier, 2004. From Epidemiology, Clinical Medicine, Molecular Biology, and Atoms, to Politics: A Review of the Relationship between Thimerosal and Autism.

  • E.H. Granai, 2004. Are Some Cases of Autism the Result of a Persistent, Attenuated Rubella Infection in the Mother?

  • E.H. Granai, 2004. The Phenomenon of a Concentration of Autistic Children’s Births in the Months of March and August.

  • B. Haley, 2004. Biomedical Aspects of Thimerosal Exposure.

  • S.J. James, 2004. Impaired transsulfuration and oxidative stress in autistic children: Improvement with targeted nutritional intervention (submitted by J. Bradstreet).

  • V. Singh, 2004. Autism, Vaccines, and Immune Reactions.

4)TRANSCRIPTS AND CONGRESSIONAL RECORDS

  • Congressional Record—Extension of Remarks. May 20, 3003. Mercury in Medicine Report. Hon. Dan Burton of Indiana, In the House of Representatives (submitted by Mark and David Geier).

  • Dan Burton. May 2003. Mercury in Medicine; Taking Unnecessary Risks. (A report Prepared by the Staff of the Subcommittee on Human Rights and Wellness, Committee on Government Reform, United States House of Representatives) (submitted by Mark and David Geier).

  • Dan Burton (Chairman): Opening statement; “FACA: Conflicts of Interest and Vaccine Development: Preserving the Integrity of the Process. June 15, 2000. Washington, DC. (submitted by R. Gallup, The Autism Autoimmunity Project).

Page 196ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
  • Simpsonwood Transcript.Scientific Review of Vaccine Safety Datalink Information, June 7-8, 2000. Simpsonwood Retreat Center, Norcross, GA (submitted by M. and D. Geier).

  • Transcript from the High Court of Justice hearing in the matter of MMR/ MR vaccine litigation, Case Management Conference (submitted by D. Salisbury).

  • Transcript—U.S. House of Representatives, Government Reform Committee holds a hearing on the status of the research into vaccine safety and autism. 6/19/02 (submitted by J. Bradstreet).

5)QUESTIONS TO CONSIDER

Several people emailed questions for the committee to consider while reviewing the research regarding autism, thimerosal, MMR, and mercury. They included:

  • Raymond Gallup, 2004. Question???-February 9, 2004 meeting-autism and vaccines.

  • Tonya Harbison, 2004. Autism.

  • Michelle Mitchell, 2004. Topics for discussion in vaccine/autism meetings.

6)NEWS ARTICLES

The committee also received news articles, including those listed below.

  • Assessing the Role of Mercury in Autism. 2002. By: Boyd E. Haley.Mothering Magazine (submitted by Moms Against Mercury).

  • Autism in a Needle? The toxic tale of vaccinations and mercury poisoning (11/11/03) By: Annette Fuentes (submitted by M. and D. Geier).

  • Methylmercury Toxicology Probed. By: Louisa Wray Dalton (submitted by J. Bradstreet).

  • New Research Suggests Link Between Vaccine Ingredients and Autism, ADHD (submitted by Becky Nelson).

  • The Irresponsible Media Coverage of the Institute of Medicine Meeting on Autism and Vaccines. By: Sandy Mintz, RFD Columnist (submitted by Philip Rudnick, West Chester University of Pennsylvania).

  • Vaccine and Autism (12/29/03) and Autism and Vaccines (2/9/04) (submitted by Deborah Wexler, Immunization Action Coalition).

  • Water in D.C. Exceeds the EPA Lead Limit; Random Tests Last Summer Found Levels in 4,000 Homes Throughout City. 1/31/04. By: D. Nakamura (submitted by J. Bradstreet).

Page 192ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
Page 192
Page 193ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
Page 193
Page 194ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
Page 194
Page 195ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
Page 195
Page 196ShareCite
Suggested Citation:"Appendix E: Summary of Public Submissions." Institute of Medicine. 2004.Immunization Safety Review: Vaccines and Autism. Washington, DC: The National Academies Press. doi: 10.17226/10997.
×
Page 196
Next:Appendix F: Acronyms »
Immunization Safety Review: Vaccines and Autism Get This Book
×
 Immunization Safety Review: Vaccines and Autism
Buy Paperback | $53.00Buy Ebook | $42.99
MyNAP members save 10% online.
Login orRegister to save!
Download Free PDF

This eighth and final report of the Immunization Safety Review Committee examines the hypothesis that vaccines, specifically the measles-mumps-rubella (MMR) vaccine and thimerosal-containing vaccines, are causally associated with autism. The committee reviewed the extant published and unpublished epidemiological studies regarding causality and studies of potential biologic mechanisms by which these immunizations might cause autism.Immunization Safety Review: Vaccines and Autism finds that the body of epidemiological evidence favors rejection of a causal relationship between thimerosal-containing vaccines and autism. The book further finds that potential biological mechanisms for vaccine-induced autism that have been generated to date are only theoretical. It recommends a public health response that fully supports an array of vaccine safety activities and recommends that available funding for autism research be channeled to the most promising areas. The book makes additional recommendations regarding surveillance and epidemiological research, clinical studies, and communication related to these vaccine safety concerns.

READ FREE ONLINE

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No ThanksTake a Tour »
  2. ×

    Show this book'stable of contents, where you can jump to any chapter by name.

    « BackNext »
  3. ×

    ...or use these buttons to go back to theprevious chapter or skip to thenext one.

    « BackNext »
  4. ×

    Jump up to theprevious page or down to thenext one. Also, you can type in a page number and pressEnter to go directly to that page in the book.

    « BackNext »
  5. ×

    Switch between theOriginal Pages, where you can read the report as it appeared in print, andText Pages for the web version, where you can highlight and search the text.

    « BackNext »
  6. ×

    Tosearch the entire text of this book, type in your search term here and pressEnter.

    « BackNext »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « BackNext »
  8. ×

    View oursuggested citation for this chapter.

    « BackNext »
  9. ×

    Ready to take your reading offline? Click here tobuy this book in print ordownload it as a free PDF, if available.

    « BackNext »
Stay Connected!

Get Email Updates

×

Do you enjoy reading reports from the Academies onlinefor free? Sign up for email notifications and we'll let you know about new publications in your areas of interest when they're released.


[8]ページ先頭

©2009-2025 Movatter.jp